^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Vulvar Cancer |
| Drug: | Opdivo (nivolumab) (PD1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/26/2021
Excerpt:
…the panel added nivolumab as as second-line, useful in certain circumstances option for HPV-related advanced or recurrent/metastatic vulvar cancer.
